Takeshian Azita MD is categorized under Internal Medicine Practitioners in Birmingham, AL and active since 1993.
Takeshian Azita MD was established in 1993, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Azita Takeshian at the company’s single location by writing to 52 Medical Park Drive East # 317, Birmingham, Alabama AL 35235 or by phoning (205) 838-3770. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Takeshian Azita MD |
| Contact Person: | Azita Takeshian |
| Address: | 52 Medical Park Drive East # 317, Birmingham, Alabama 35235 |
| Phone Number: | (205) 838-3770 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1993 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Takeshian Azita MD was started in 1993 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Azita Takeshian for inquiries that concern Takeshian Azita MD by calling the company number (205) 838-3770, as your correspondence is most welcome. Additionally, the physical location of the single location of Takeshian Azita MD can be found at the coordinates 33.594557,-86.665595 as well as the street address 52 Medical Park Drive East # 317 in Birmingham, Alabama 35235.
For its online presence, you may visit Takeshian Azita MD’s website at and engage with its social media outlets through on Twitter and on Facebook.